'Challenged' Novartis looks to cut 440 UK jobs
Swiss pharmaceuticals giant Novartis said on Wednesday that it aimed to slash more than 440 jobs in Britain, blaming industry-wide difficulties.
The Basel-based company said it is considering closing its manufacturing site in Horsham, West Sussex, which would lead to the evaporation of 371 jobs, the company told AFP in an email, confirming a report by the FierceBiotech website.
The closure was needed as Novartis attempts to adapt to "a challenging healthcare marketplace," it said, stressing that the decision was still subject to consultations with employees and final approval by its UK board.
"We understand that this will be a difficult time for potentially affected employees, their families and the wider Horsham community given the links the company has in the area," Novartis said, vowing to do its utmost to "make the process as straightforward and smooth as possible."
Two years ago, Novartis announced plans to halt manufacturing at the site and to cut staff numbers there from 950 to 450 people, but the group said on Wednesday that it now also aimed to close a unit dedicated to respiratory research.
Novartis also said that cuts at its UK pharmaceuticals division in Frimley, Surrey, could impact another 72 jobs.
The company currently employs more than 3,000 people in Britain.
Comments
See Also
The Basel-based company said it is considering closing its manufacturing site in Horsham, West Sussex, which would lead to the evaporation of 371 jobs, the company told AFP in an email, confirming a report by the FierceBiotech website.
The closure was needed as Novartis attempts to adapt to "a challenging healthcare marketplace," it said, stressing that the decision was still subject to consultations with employees and final approval by its UK board.
"We understand that this will be a difficult time for potentially affected employees, their families and the wider Horsham community given the links the company has in the area," Novartis said, vowing to do its utmost to "make the process as straightforward and smooth as possible."
Two years ago, Novartis announced plans to halt manufacturing at the site and to cut staff numbers there from 950 to 450 people, but the group said on Wednesday that it now also aimed to close a unit dedicated to respiratory research.
Novartis also said that cuts at its UK pharmaceuticals division in Frimley, Surrey, could impact another 72 jobs.
The company currently employs more than 3,000 people in Britain.
Join the conversation in our comments section below. Share your own views and experience and if you have a question or suggestion for our journalists then email us at [email protected].
Please keep comments civil, constructive and on topic – and make sure to read our terms of use before getting involved.
Please log in here to leave a comment.